Title of Invention

"A COMPOUND COMPRISING A NAPHTHOQUINONE DERIVATIVE OF FORMULA (I) AND ITS COMPOSITION THEREOF"

Abstract A compound comprising a naphthoquinone derivative of formula (I) or a salt thereof, in which m is 0 or 1; n represents an integer from 0 to 4; each R independently represents a halogen atom or a nitro, cyano, hydroxyl, alkyl, haloalkyl, aikoxy, haloalkoxy, amino, alkylamino, dialkylamino, alkoxycarbonyl, carboxyl, alkanoyl, alkylthio, alkylsulphinyl, alkylsulphonyl, carbamoyl, alkylamido, cycloalkyl, aryl or aralkyl group; in which R1, R2, R3, R4, R5, R6, R7, R8 are as described in the specification.
Full Text PESTICIDAL COMPOUNDS
This invention relates to certain naphthoquinone derivatives, a process for their
preparation, compositions containing such compounds and their use as pesticides, such as
fungicides and, especially, insecticides and/or acaricides.
DE3801743 Al generically discloses compounds of the general formula
(A)
(CH2)n-R2
0
in which n is 0 to 12, R1 represents hydrogen or an optionally substituted alkyl, aralkyl,
alkylcarbonyl, (hetero)arylcarbonyl, alkoxycarbonyl, alkylsulphonyl or arylsulphonyl
group, and R2 represents a haloalkyl, optionally substituted (hetero)aryl or substituted
cycloalkyl group, which are said to exhibit acaricidal and fungicidal activity. When R2
represents a phenyl or cyclohexyl group, the list of preferred substituents includes
tri-(C1-2 alkyl)silyl groups and, of these, a trimethylsilyl group is especially preferred.
However, of the many compounds specifically disclosed which fall within formula I as
defined above, only one compound is disclosed which contains such a substituent, that is
the compound of Example 5 in which n is 0, R1 is a hydrogen atom and R^ is a
4-(trimethylsilyl)cyclohexyl group. Moreover, although data is provided which indicates
that the compound of Example 5 exhibits some acaricidal and fungicidal activity, it is
apparent that this compound is not the most pesticidally active compound of those
compounds specifically disclosed in DE 3801743 Al.
It has now been discovered that certain naphthoquinone derivatives which bear a
group attached to the naphthoquinone ring which includes at least one silicon atom as an
integral part of the group rather than as part of an optional substituent exhibit superior
pesticidal, for instance, ftmgicidal and/or, especially, insecticidal and/or acaricidal, activity
and that many of these compounds are active against resistant strains of insects and/or
acarids, especially resistant strains of aphids, mites and whitefly, as well as susceptible
strains.
-1ftAccording
to the invention there is therefore provided a compound of the general
formula
(I)
R8 R7
or a salt thereof, in which
m is 0 or 1;
n represents an integer from 0 to 4:
each R independently represents a halogen atom or a nitro, cyano, hydroxyl, alkyl,
haloalkyl, alkoxy, haloalkoxy, amino, alkylamino, dialkylamino, alkoxycarbonyl, carboxyl,
alkanoyl, alkylthio, alkylsulphinyl, alkylsulphonyl, carbamoyl, alkylamido, cycloalkyl, aryl
or aralkyl group;
R1 and R2 each independently represent an optionally substituted alkoxy group or together
represent a group =O, =S or =N-OR9, where R9 represents a hydrogen atom or an
optionally substituted alkyl group;
R^ represents an optionally substituted alkyl group, a hydroxyl group, a group -OL where
L is a leaving group or a group which in vivo is transformed into a group -OL1 where L1
is a leaving group;
R4 and R5, if present, each independently represent a hydrogen or halogen atom or an
optionally substituted alkyl group or together with the interjacent carbon atom represent an
optionally substituted cycloalkyl or cycloalkenyl group optionally containing at least one
ring-silicon atom;
R^ represents an optionally substituted group containing at least one silicon atom or, in the
case where m is 1 and the -CR4R5 -moiety contains at least one silicon atom, R" may
additionally represent a hydrogen atom or an optionally substituted alkyl, alkenyl, alkynyl,
cycloalkyl, cycloalkenyl, aryl, alkoxy, alkenyloxy, alkynyloxy, cycloalkoxy,
cycloalkenyloxy or aryloxy group; and
R7 and R8 independently represent an optionally substituted alkoxy group or together
represent a group =O, =S or =N-OR9, where R9 is as previously defined.
-2-
When any of the foregoing groups R4, R5 and R6 contain at least one silicon atom,
the or each silicon atom forms an integral part of the group, that is, the or each silicon atom
is a ring or chain atom, and is not a substituent on the group. Particularly the silicon atom
is not a substituent on a carbocylic ring but may be directly connected to such a ring only
when it is part of a chain which includes the 1' position carbon atom of the carbocyclic ring.
When the compounds of formula I contain an alkyl, alkenyl or alkynyl substituent
group, this may be linear or branched and may contain up to 12, preferably up to 6 and
especially up to 4, carbon atoms. A cycloalkyl or cycloalkenyl group may contain from 3
to 8, preferably 4 to 7, carbon atoms. An aryl group may be any aromatic hydrocarbon
group, especially a phenyl or naphthyl group. An aralkyl group may be any alkyl group as
defined above which is substituted by an aryl group as defined above, especially a benzyl
group.
When any of the foregoing substituents are designated as being optionally
substituted, the substituent groups which are optionally present may be any one or more of
those customarily employed in the development of pesticidal compounds and/or the
modification of such compounds to influence their activity, persistence, penetration or other
property. Specific examples of such substituents include, for example, halogen atoms,
nitro, cyano, hydroxyl, alkyl, haloalkyl, alkoxy, haloalkoxy, amino, alkylamino,
dialkylamino, alkoxycarbonyl, carboxyl, alkanoyl, alkylthio, alkylsulphinyl,
alkylsulphonyl, carbamoyl, alkylamido, cycloalkyl, phenyl and benzyl groups. Typically,
0-3 substituents may be present. When any of the foregoing substituents represents or
contains an alkyl substituent group, this may be linear or branched and may contain up
to 12, preferably up to 6, and especially up to 4, carbon atoms. When any of the foregoing
substituents represents or contains an aryl or cycloalkyl moiety, the aryl or cycloalkyl
moiety may itself be substituted by one or more halogen atoms, nitro, cyano, alkyl,
haloalkyl, alkoxy or haloalkoxy groups. Preferably, the aryl moiety is a phenyl moiety and
the cycloalkyl moiety contains from 3 to 8, especially 4 to 7, carbon atoms.
Compounds of formula I in which R3 represents a hydroxyl group and the atom at
the a- and β-positions, particularly the β-position, of the group R6 is a silicon atom are
synthetically less accessible than other compounds of formula I. It is therefore preferred
that, if R3 represents a hydroxyl group, then the atom at the a- and/or P-position of the
-3-
group R6 is not a silicon atom.
It is also preferred that R, if present, represents a halogen atom or a nitro, cyano,
hydroxyl, C1-4 alkyl, C1.4haloalkyl, C 1.4alkoxy, C 1-4haloalkoxy, C 1_4alkylamino, di-C 1-.4
alkylamino, C1_4 alkoxycarbonyl, C M alkylthio, C Malkylsulphinyl or C 1.4alkylsulphonyl
group.
More preferably, R, if present, represents a halogen atom or a Cj_4 alkyl, Cj_4
haloalkyl, Cj_4 alkoxy or C^ haloalkoxy group.
Preferably, n is 0, 1 or 2 and it is especially preferred that n is 0.
It is also preferred that R^ and R^ each independently represent a C^ alkoxy,
especially a methoxy, group or together represent a group =O or =N-OR^, where R^
represents a hydrogen atom or a Cj_4 alkyl, especially a methyl, group.
It is especially preferred that R* and R^ together represent a group =O.
When R3 represents a group -OL where L is a leaving group or a group which
in vivo is transformed into a group -OL^ where LMs a leaving group, the leaving groups
L and L* may be any group customarily employed as a leaving group. However, it is
preferred that the leaving groups L and L^ are such that the pIC, value of the acids LOH and
L^OH in water is below 7, more preferably below 6 and especially below 5.
When R3 represents a group which in vivo is transformed into a group -OL^ where
LMs a leaving group, it is preferred that the transformation occurs in a plant to be protected
or in the pest, preferably by the action of enzymes within the plant or pest. For instance,
if R3 represents a fl-acid group, such as -O-CH2CH2CO-OH where -CH2CH2CO-OH is
not a leaving group, it may be subjected to enzymatic oxidation in vivo, by for example,
a B-oxidase, to form a group -O-CO-CH2-CO-OH where -CO-CH2-CO-OH is a leaving
group.
It is preferred that R3 represents an optionally substituted alkyl group or a group
-OR10 where R10 represents a hydrogen atom, an optionally substituted alkyl, aryl or
aralkyl group or a group -CO-R11, -SO-R11, -S02-RU ,-P(X)(OFi2 )(OR3 ),
-P(X)(R12)(OR13), -P(OR12)(OR13) or -P(R12)(OR13) where R11 represents a hydrogen
atom, an optionally substituted alkyl, aryl or aralkyl group or a group - NR12R13;R12 and
R13 independently represent a hydrogen atom or an optionally substituted alkyl group and
X represents an oxygen or sulphur atom. When R10 or R11 represents an optionally
-4-
substituted aryl or aralkyl group, it is preferred that the aryl group or moiety is a phenyl
group or moiety and that the optional substituents are selected from halogen atoms, nitro
and CM alkyl groups. Substitution at the 4-position of the phenyl ring is particularly
preferred.
Preferably, R3 represents a C j_6 alkyl group or, more preferably, a hydroxyl group
or a group -O-CO-R11 where R11 represents a hydrogen atom or a C M2 alkyl, Cj_
12 haloalkyl, C j.]2 hydroxyalkyl, C M2 carboxylalkyl, phenyl or benzyl group.
It is particularly preferred that R3 represents a hydroxyl group or a group
-O-CO-R11 where R11 represents a hydrogen atom or a Cl,6 alkyl, Cj_6 haloalkyl, phenyl
or benzyl group.
In one preferred aspect, R4 and R5 may each independently represent a hydrogen
atom or a C M alkyl, especially methyl, or Cj_4 haloalkyl, especially trifluoromethyl,
group. More preferably, R4 and R5 both represent a hydrogen atom.
Alternatively, R4 and R5 together with the interjacent atom may represent a C3_
8 cycloalkyl group optionally substituted by one or more substituents selected from halogen
atoms, Cj_4 alkyl and C^ haloalkyl groups. More preferably, R4 and R5 together with the
interjacent atom represent a C3.8 cycloalkyl group optionally substituted by one or more
halogen, especially chlorine or bromine, atoms. It is particularly preferred that R4 and R5
together with the interjacent atom represent an unsubstituted C5.7 cycloalkyl group.
When R4 and R5 have any of the significations given in the immediately preceding
two paragraphs, R6 must represent a group containing at least one silicon atom. It is
therefore preferred that R6 represents an optionally substituted alkyl, alkenyl, alkynyl,
cycloalkyl, cycloalkenyl, aryl, alkoxy, alkenyloxy, alkynyloxy, cycloalkoxy,
cycloalkenyloxy or aryloxy group, each group containing at least one silicon atom and up
to 20, especially up to 15, and preferably 2 to 12, carbon atoms.
More preferably, R^ represents an alkyl, haloalkyl, alkoxyalkyl, alkoxy, haloalkoxy,
alkoxyalkoxy, alkenyl, haloalkenyl or alkoxyalkenyl group, each group containing one or
two silicon atoms and up to 20, especially up to 15, and preferably 2 to 12 carbon atoms.
It is further preferred that R^ represents an alkyl or alkenyl group containing one
silicon atom and up to 20, especially up to 15, and preferably 2 to 12 carbon atoms.
Preferred groups R6 are of formula -(A)m-Si(R14 ) 3 where m is as defined for
-5-
formula (I) each R14 is independently Cj_4 alkyl or with the interjacent silicon two such
groups aform a siliacarbocyclic ring, and A is a Cj.2o alkyl or alkenyl group, which may
be substituted with halogen, and which may be straight, branched or be or include a
carbocyclic ring. Further preferred groups R6 include silicon as a ring atom in an otherwise
carbocyclic ring where it may be at any ring posistion, including the point of attachment
to other groups such as an alkyl or alkenyl chain in R6.
More preferably, R6 represents a group -(CH2)p-Si(R14 ) where p represents an
integer from 1 to 15, preferably 1 to 10 and especially 1 to 6, and each R14 independently
represents a C 1-4 alkyl, especially methyl, group. Alternatively two groups R14 may form
a 3-8 membered silacarbocyclic, eg. silacycloalkyl, ring together with the interjacent silicon
atom shown.
In another preferred aspect, R4 and R5 together with the interjacent carbon atom
may represent a silacycloalkyl group containing from 3 to 8, preferably 5 to 7, ring atoms
optionally substituted by one or more substituents selected from halogen atoms, C^ alkyl
and C]_4 haloalkyl groups. More preferably, R4 and R5 together with the interjacent carbon
atom represent a silacycloalkyl group containing from 3 to 8, preferably 5 to 7, ring atoms
optionally substituted by one or more halogen, especially chlorine or bromine, atoms. It
is particularly preferred that R4 and R5 together with the interjacent carbon atom represent
an unsubstituted silacycloalkyl group containing from 5 to 7 ring atoms. Preferably, the
silacycloalkyl group contains one or two silicon atoms, more preferably only one silicon
atom.
When R^ and R^ have any of the significations given in the immediately preceding
paragraph, it is preferred that R^ represents a hydrogen atom or an optionally substituted
alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, alkoxy, alkenyloxy, alkynyloxy,
cycloalkoxy, cycloalkenyloxy or aryloxy group, each group optionally containing at least
one silicon atom and up to 20, especially up to 15, and preferably 2 to 12 carbon atoms.
More preferably, R6 represents a hydrogen atom or an alkyl, haloalkyl, alkoxyalkyl,
alkoxy, haloalkoxy, alkoxyalkoxy, alkenyl, haloalkenyl or alkoxyalkenyl group, each group
optionally containing one or two silicon atoms and up to 20, especially up to 15, and more
preferably from 2 to 12 carbon atoms.
It is further preferred that R*> represents an alkyl or alkenyl group optionally
-6-
containing one silicon atom and up to 20, especially up to 15, and more preferably from 2
to 12 carbon atoms.
Preferably, R' and R° independently represent a Cj_4 alkoxy, especially a
methoxy, group or together represent a group =O or =N-OR^, where R^ represents a
hydrogen atom or a C 1.4 alkyl, especially a methyl, group.
It is especially preferred that R' and R° together represent a group =O.
A particularly preferred sub-group of compounds of formula I is that in which
m is 1; n is 0; R^ and R^ both represent a methoxy group or together represent a
group =O; R^ represents a hydroxy, alkynoxy, (eg. ethanoyloxy) or aryloxyl
(eg.benzoyloxy) group; R^ and R-> both represent a hydrogen atom; R^ represents a
trimethylsilylmethyl, trimethylsilylethyl, trimethylsilylpropyl, trimethylsilylbutyl,
trimethylsilylpentyl, trimethylsilylhexyl, trimethylsilylheptyl, trimethylsilyloctyl,
trimethylsilylnonyl or trimethylsilyldecyl group; and R' and R° together represent a
group =O.
The compounds of formula I may form salts when R^ represents a hydroxyl group.
Suitable bases for forming such salts include inorganic bases, such as sodium hydroxide,
potassium hydroxide and sodium carbonate, and organic bases, especially tertiary amines,
such as triethylamine and pyrrolidine.
It should also be appreciated that some of the compounds of formula I are capable
of existing as different geometric isomers and diastereomers. The invention thus includes
both the individual isomers and mixtures of such isomers.
The present invention also provides a process for the preparation of a compound of
formula I or a salt thereof as defined above which comprises reacting a compound of the
general formula (II)
(II)
in which n, R and R^ are as defined above with a carboxylic acid HOOC-(CR^R^)'mm-R",
-7-
where m, R.4, R^ and Rr are as defined above with the proviso that, when m is 0, the atom
at the a-position of the group R" is not a silicon atom, in the presence of a free radical
initiator, such as ammonium peroxysulphate and silver nitrate in a suitable solvent, such
as aqueous acetonitrile, to form a compound of the general formula (III)
in which m, n, R-% R^, R^ and R" are as defined above with the proviso that, when m is 0,
the atom at the a-position of the group R" is not a silicon atom.
Compounds of formula III correspond to compounds of formula I in which R^ and
R^ together and R^ and R^ together represent a group =O and may then be further reacted
using various known derivatisation processes or combinations thereof to obtain further
compounds of formula I, as desired.
For instance, compounds of formula II in which R^ represents a group
-O-CO-CgH5 are convenient starting materials and may be reacted as described above to
form the corresponding compound of formula III. Compounds of formula I in which R^
represents a hydroxyl group may then be prepared by reacting the compound of formula III
in which R^ represents a group -O-CO-Cgl^ with a suitable base, for instance, an
inorganic base, such as sodium hydroxide or potassium hydroxide, in the presence of a
suitable solvent, such as tetrahydrofuran. Compounds of formula I in which R^ represents
a group -OL, where L is as defined above, may be prepared by reacting a compound of
formula I in which R^ represents a hydroxyl group with a compound Y-L, where
Y represents a halogen atom, in the presence of an organic base, preferably a tertiary amine
such as triethylamine, or an inorganic base, such as sodium carbonate. For instance,
compounds of formula I in which R^ represents a group -O-CO-R11, where R11 is as
defined above, may be prepared by acylation of the hydroxyl group in a suitable compound
of formula I, for instance, by using an acyl chloride R^ 1-CO-C1 in a suitable solvent, such
as dichloromethane, in the presence of a base, such as triethylamine, or an acid anhydride
-8-
in the presence of a base, such as pyridine. Alternatively, compounds of formula I in which
R-5 represents a hydroxyl group may be reacted with a compound HO-L, where L is as
defined above, in the presence of a dehydrating agent, such as dicyclohexylcarbodiimide.
Compounds of formula I in which Ry represents a group -OL, where L is as defined above,
may also be prepared by reacting a metal salt of a compound of formula I in which R^
represents a hydroxyl group, that is, R^ represents a group -OM where M is a metal ion,
with a compound Y-L as defined above.
Compounds of formula I in which R^ and R2 and/or R7 and R^ each independently
represent an optionally substituted alkoxy group may be prepared by ketalisation of one or
both carbonyl groups in a suitable compound of formula III, for instance, by using a
suitable alcohol in basic or acidic conditions, such as potassium hydroxide in methanol.
Compounds of formula I in which R^ and R2 together and/or R7 and R^ together
represent a thiocarbonyl group =S may be prepared by treating a suitable compound of
formula III with a thiating agent, such as Lawesson's Reagent (2,4-bis(4-methoxyphenyl)-
l,3-dithia-2,4-diphosphetane-2,4-disulphide), using protecting groups where required.
Compounds of formula I in which R1 and R2 together and/or R7 and R^ together
represent an oxime group =N-OR^, where R^ is as defined above, may be prepared by
treating a suitable compound of formula III with a hydroxylamine or alkoxylamine of
formula R^O-NH^, where R^ is as defined above, in the presence of a base, such as
pyridine.
In an alternative process for preparing compounds of formula I, particularly in
which m is 0 and the atom at the a-position of the group R" is a silicon atom, a compound
of the general formula (IV)
0
Hal
(IV)
where each Hal independently represents a halogen, preferably a chlorine or bromine, atom
and n and R are as defined above, is reacted with a compound of the general formula Z-R",
where Z represents a halogen, preferably a chlorine or bromine, atom and R" is as defined
-9-
above particularly with the proviso that the atom at the a-position of the group R^ is a
silicon atom, in the presence of an organometallic reagent, such as butyl lithium, in a
solvent, such as diethyl ether or tetrahydrofuran, at low temperature, preferably -70°C to
-120°C, to form a compound of the general formula (V)
(V)
in which n, R, R" and Hal are as defined above, particularly with the proviso that the atom
at the a-position of the group R^ is a silicon atom.
The compound of formula V may then be reacted with a suitable base, for instance,
an inorganic base, such as sodium hydroxide or potassium hydroxide, to form the
corresponding compound of formula I in which R^ represents a hydroxyl group.
Combinations of the derivatisation processes described above may then be
performed to obtain further compounds of formula I, as desired.
Compounds of formula II and IV are known compounds or can be prepared from
known compounds by processes analogous to known processes.
As mentioned above, the compounds of general formula I have been found to have
pesticidal, for instance, fungicidal and/or, especially, insecticidal and/or acaricidal, activity.
Accordingly, the invention further provides a pesticidal composition which comprises a
carrier and, as active ingredient, a compound of formula I or a salt thereof as defined above.
A method of making such a composition is also provided which comprises bringing a
compound of formula I as defined above into association with at least one carrier. Such a
composition may contain a single compound or a mixture of several compounds of the
present invention. It is also envisaged that different isomers or mixtures of isomers may
have different levels or spectra of activity and thus compositions may comprise individual
isomers or mixtures of isomers.
The compositions of the invention may contain from 0.001 to 95% by weight of the
-10-
active ingredient of formula I. Preferably the compositions contain from 0.001 to 25% by
weight of the active ingredient when they are in ready-to-use form. However, higher
concentrations, for instance, up to 95%, may be present in compositions to be sold as
concentrates for dilution before use.
The compounds of the invention may be mixed with a variety of appropriate inert
carriers such as solvents, diluents and/or surface-active agents to form dusts,
granular solids, wettable powders, mosquito coils or other solid preparations or emulsions,
emulsifiable concentrates, sprays, aerosols or other liquid preparations. Suitable solvents
and diluents include water, aliphatic and aromatic hydrocarbons such as xylene or other
petroleum fractions and alcohols such as ethanol. Surface-active agents may be of an
anionic, cationic or non-ionic type. Anti-oxidants or other stabilisers may also be included
as well as perfumes and colourings. These inert carriers may be of the type and in
proportions such as are conventionally used in pesticidal compositions.
In addition to these inert carriers, the compositions of the invention may also
contain one or more further active ingredients. These further active ingredients may be
other compounds which exhibit pesticidal activity and these other compounds may exhibit
a synergistic effect with the compounds of the present invention.
The compounds of formula I as defined above may be used to control pest
infestation in domestic, horticultural, agricultural, medical or veterinary environments.
Thus, according to another aspect of the present invention there is provided the use as a
pesticide, for instance, a fungicide and/or, especially, an insecticide and/or acaricide, of a
compound of formula I or a salt thereof as defined above or a composition as defined
above.
The present invention also provides a method of combating pests, such as fungi
and/or, especially, insects and/or acarids, at a locus which comprises treating the locus with
a compound of formula I or a salt thereof as defined above or a composition as defined
above. Preferably, the locus comprises the pests per se or environments subject to or
subjected to attack by pests. More preferably, the locus comprises the pests per se, stored
food material, plants or animals subject to or subjected to attack by pests, seeds of such
plants or the medium in which such plants are growing or are to be grown. Specifically,
compounds of formula I and compositions as defined above may be used in a domestic
-11-
environment for spraying rooms to combat infestation by houseflies or other insects, in a
horticultural or agricultural environment for treatment of stored crops, especially cereals,
or to spray growing crops such as cotton or rice to combat infestation by fungi, insects or
other pests, and in a medical or veterinary environment, for instance, as a cattle spray to
prevent or treat infestation by insects or other pests.
The present invention will now be further described by way of illustration only by
reference to the following non-limiting examples. In these, structures of compounds are
confirmed by assigned 13C nmr shifts (in ppm.), listed in the order: bicyclic system; CH2's
(and =CH's if present); Si(alk)3 group; other groups. Further examples falling within the
scope of the claims will occur to those skilled in the art in the light of these.
EXAMPLES
Example 1
Preparation of 2-benzoyloxy-3-(2'-trimethylsilylethylV 1.4-naphthoquinone
(Formula I : m=l; n=0; R* and R2 together and R' and R8 together
both represent =Q: R3 = -O-CO-C6H5: R4 = R5= H: R6 = -CH2SifCH3ty
2-Benzoyloxy-l,4-naphthoquinone (1.39 g, 5 mmol), trimethylsilylpropionic acid
(1.09 g, 7.5 mmol) and silver nitrate (523 mg, 3 mmol) were suspended in 40 ml aqueous
acetonitrile (1:1) and then heated to 65°C. Ammonium persulphate (1.71 g, 7.5 mmol) in
20 ml water was added slowly and dropwise over 30 minutes to the mixture. The reaction
mixture was stirred at this temperature for a further hour and then cooled, diluted with
diethyl ether and the aqueous phase removed. The organic extract was washed with
saturated sodium bicarbonate solution, then brine and dried over anhydrous magnesium
sulphate. After concentration in vacuo. the crude material was chromatographed using
petroleum ether/ethyl acetate as eluent to give 2-benzoyloxy-3-(2'-trimethylsilylethyl)-l,4-
naphthoquinone (879 mg) which was recrystallised from methanol, m.pt.: 92-95°C. NMR
peaks at: 184.4, 178.2, 150.3, 142.6, 134.0, 133.8, 132.1,130.9, 126.6, 126.6; 18.8, 16.2;
-2.0; 163.8, 128.0, 128.7, 130.4, 134.2 (PhCO).
Example 2
Preparation of 2-hydroxy-3-(2'-trimethylsilylethyl)-l.4-naphthoquinone
(Formula I : m=l; n=0; R1 and R2 together and R7 and R8 together
-12-
both represent =O: R3 = -OH: R4 = R5 = H: R6 = -C ~ """" •*• ^^—— _r . • _ ...i..i._i •
2-Benzoyloxy-3-(2'-trimethylsilylethyl)-l,4-naphthoquinone(270mg, 0.71 mmol) obtained
as in Example 1 above in tetrahydrofuran (10 ml) was treated with 2N sodium hydroxide
(0.73 ml, 1.42 mmol) and the mixture stirred overnight at room temperature. The reaction
mixture was concentrated in vacuo and the residue taken up in diethyl ether and acidified
to pH 2 with IN hydrochloric acid. The organic phase was washed with brine, dried over
anhydrous magnesium sulphate and concentrated in vacuo. The crude material was
chromatographed using ethyl acetate/petroleum ether as eluent to give 2-hydroxy-3-(2'-
trimethylsilylethyl)-l,4-naphthoquinone (163 mg) which was recrystallised from hexane,
m. pt. 98-100°C.NMRpeaksat: 184.6, 181.6, 152.2, 134.7, 132.9, 132.8, 129.4, 127.3,
126.6,126.0; 17.6, 15.7;-1.9.
Example 3
Preparation of 2-hydroxy-3(5'-trimethylsilylpentyl)-1.4-naphthoquinone
(Formula I : m=l; n=0; R^ and R^ together and R^ and R° together
both represent =O: R3 = -OH: R4 - R5 = H: R6 = -rCH2l/|SifCH3ty
2-Hydroxy-3(6'-trimethylsilylhexyl)-l,4-naphthoquinone (337 mg, 1.02 mmol), prepared
from 2-benzoyloxy-l,4-naphthoquinone and trimethylsilylheptanoic acid by the method of
Example 1 followed by the method of Example 2, was dissolved in dioxane (2.5 ml) under
nitrogen. Sodium carbonate (120 mg) in water (2.5 ml) was added followed by an excess
of 30% (w/v) hydrogen peroxide (200 ui). The mixture was heated at 70°C for 40 minutes
during which time the reaction mixture turned from red to colourless. The reaction mixture
was allowed to cool and 20% (w/v) copper sulphate solution (100 ul) was added and the
solution stirred until bubbling ceased. 25% (w/v) sodium hydroxide solution (2 ml) and
20% (w/v) copper sulphate solution (5 ml) were then added and the reaction mixture heated
at 70°C for 30 minutes. The mixture was allowed to cool and acidified to pH 2 with IN
hydrochloric acid. The product was extracted into diethyl ether and the ether extract was
then washed with brine, dried over anhydrous magnesium sulphate and concentrated
in vacuo. The crude material was chromatographed using 5% diethyl ether/hexane as
eluent to give 2-hydroxy-3(5'-trimethylsilylpentyl)-l,4-naphthoquinone (202 mg) which
was recrystallised from hexane, m. pt. 73-75°C. NMR peaks at: 184.6,181.4,153.0,134.8,
132.9, 132.7, 129.4, 126.7, 126.0, 124.8; 33.6, 27.9, 33.7, 23.2, 16.5; -1.7.
-13-
Example 4
Preparation of 2-ethanoyloxy-3 -(2'-trimethylsilylethylV 1.4-naphthoquinone
(Formula I : m=l; n^O; R1 and R2 together and R7 and R8 together
both represent =0: R3 --O-CO-CH3: R4 = R5 = H: R6 = -CH2Si(CH3)3)
2-Benzoyloxy-3-(2'-trimethylsilylethyl)-l ,4-naphthoquinone (346 mg, 0.92 mmol) obtained
as in Example 1 above was hydrolysed as in Example 2 above and the hydrolysed material
was acetylated directly by the addition of pyridine (6 ml) and acetic anhydride (3 ml).
After standing overnight, the volatiles were removed in vacuo. The crude material was
chromatographed using ethyl acetate/petroleum ether as eluent to give 2-ethanoyloxy-3- (2'-
trimethylsilylethyl)-l,4-naphthoquinone (265 mg) which was recrystallised from hexane
m. pt. 85-87°C. NMR peaks at: 184.3, 178.2, 149.8, 142.2, 134.0, 133.7, 132.0, 130.8,
126.5, 126.4; 18.6, 16.1; -2.1; 167.9, 20.2 (COCH3).
Example 5
Preparation of 2-hydroxy-3-(2'-trimethylsilylethyl)-1.4-naphthoqumone. 1-dimethyl acetal
Formula I : m=l; n=0; R1 = R2 - -OCH3; R3 = -OH; R4 = R5 - H;
R6 = -CH2Si(CH3ty: R7 and R8 together represent =O
2-Ethanoyloxy-3-(2'-trimethylsilylethyl)-l,4-naphthoquinone (3 g) obtained as in
Example 4 was dissolved in methanol (100 ml), water (5 ml) and potassium carbonate
(1.5 g). The reaction mixture was stirred at room temperature for 2 hours and then diluted
with water (about 400 ml). The mixture was then extracted with diethyl ether,
dried over anhydrous sodium sulphate and the solvent evaporated to give
2-hydroxy-3-(2'-trimethylsilylethyl)-l,4-naphthoquinone, 1-dimethyl acetal as a pale
yellow solid, m. pt. 102-104°C. NMR peaks at: 183.6, 158.4,135.2,133.4,132.7,130.0,
126.2,125.6, 125.2, 97.3; 16.8,16.3; -2.1; 51.9 (2 x OMe).
Example 6 to 13
By processes similar to those described in Examples 1 to 5 above, further compounds of
formula I were prepared as detailed in Table 1 below. In this table, the compounds are
identified by reference to formula I.
-14-
TABLE 1
(In the following examples m=l; n=0; R1 & R2 together and R7 & R8 together both
represent a group =O; R4=R5=H)
10
Example
No.
6
7
8
9
10
11
12
13
R3
-OH
-OH
-OH
-OH
-OH
-OH
-OH
-OH
R6
-Si(CH3)3
-(CH2)2-Si(CH3)3
-(CH2)3-Si(CH3)3
-(CH2)5-Si(CH3)3
-(CH2)6-Si(CH3)3
-(CH2)7-Si(CH3)3
-(CH2)8-Si(CH3)3
-(CH2)9-Si(CH3)3
rn.pt. (°C)
76-78
70-71
74-76
43-45
38-42
37-40
36
nD
1.5356
NB. nD signifies refractive index for the sodium D lines.
15 NMR peaks were observed as follows;
Example 6:
NMR peaks at: 184.7, 180.8, 151.3, 134.4, 132.9,132.9,129.7,126.7, 126.0, 125.5; 15.0;
-0.8.
Example 7:184.7,181.5,154.0,134.8,132.9,132.8,129.5,127.6,126.0,125.6; 27.1,22.9,
20 17.0;-1.7.
Examples: 184.6,181.4,152.9,134.7,132.9,132.8,129.4,126.7,126.0,124.8; 32.1,24.2,
23.1, 16.4;-1.7.
Example 9: 184.6,181.4,153.0,134.7,132.8,132.6,129.4,126.7,126.0,124.8; 33.4,29.5,
28.2,23.8,23.3, 16.5;-1.7.
25 Example 10: 184.7, 181.5, 153.0, 134.8, 132.9, 132.8, 129.4, 126.8, 126.0, 124.9; 33.5,
29.7, 29.2, 28.3, 23.9, 23.4, 16.6; -1.6.
-15-
Example 11: 184.7, 181.5, 153.0, 134.8, 132.9, 132.8, 129.4, 126.7, 126.0, 124.9; 33.6,
29.8, 29.4, 29.3, 28.3, 23.9, 23.3, 16.6; -1.6.
Example 12: 184.7, 181.5, 153.0, 134.8, 132.9, 132.8, 129.5, 126.8, 126.0, 124.9; 33.6,
29.8, 29.5, 29.4, 29.3, 28.3, 23.9, 23.4, 16.7; -1.7.
Example 13: 184.6, 181.4, 153.0, 134.7, 132.9, 132.8, 129.4, 126.7, 126.0, 124.8; 33.6,
29.8, 29.6, 29.6, 29.4, 29.3, 28.3, 23.9, 23.3, 16.6; -1.7.
Example 14
Preparation of 2-hydroxy-3(8-(dimethylethylsilyl')octylV 1.4-naphthoquinone
Formula I : m=l. n=0; R1 & R2 together and R7 & R8 together both represent a group =O;
R3 = -OH; R4=R5=H and R6= -(CH2)7Si(CH3)2CH2CH3.
To magnesium turnings (1.98g, 81.5 mmol) at room temperature was added dropwise a
solution of 1,8-dibromooctane (11.Ig, 40.8 mmol) in dry THF (50 ml). When the
effervescence had ceased the mixture was refluxed for 2h to prepare octyl dimagnesium
dibromide. After cooling to room temperature, a solution of chlorodimethylethylsilane
(5.00g, 40.8 mmol) in THF (5 ml) was slowly added. After addition the reaction was
refluxed for a further Ih. Gaseous carbon dioxide was passed through the cooled reaction
mixture for 30 minutes before diluting with ether (50ml) and acidifying with dilute
hydrochloric acid. The aqueous layer was separated and extracted further with ether
(3x25ml). The combined ether layers were washed with water (2x25ml), saturated sodium
chloride solution (50ml) and dried (MgSO4). Filtration and evaporation of the solvents
under reduced pressure yielded a white waxy solid which was extracted with hexane
(3x50ml). The combined hexane extracted were evaporated under reduced pressure to yield
a colourless liquid (5.94g). This liquid was reacted with 2-benzoyloxy-l,4-
naphthoquinone, by the method described in Example 1 followed by the method described
in Example 2 to give 2-hydroxy-3(8-(dimethylethylsilyl)octyl)-l,4-naphthoquinone.
(753mg), which was recrystallised from hexane, m. pt.39-41°C. NMR peaks at:184.7,
181.5,152.9,134.8,132.9, 132.8, 129.4, 126.8, 126.0, 124.8; 33.7, 29.8, 29.4, 29.3, 28.3,
23.9,23.4, 14.8; 7.4, 6.9,-3.9.
-16-
Examples 15-17
By a process identical to that described for Example 13, further compounds of formula I
were prepared as detailed in Table 2 below. In this table, the compounds are identified by
reference to formula I.
TABLE 2
(In all the following examples m=l, n=0; R1 & R2 together and R7 & R8 together both
represent a group =O; R4=R5=H)
Example
No.
15
16
17
R3
-OH
-OH
-OH
R6
-(CH2)7-SiEt3
-(CH2)7-SiPr3
-(CH2)7-SiMe2Pr
m.pt.(°C)
51-53
48-50
45-47
NMR peaks were observed as follows;
Example 15
NMR peaks at: 184.7, 181.5, 153.0, 134.8, 132.9, 132.9, 129.4, 126.8, 126.1, 124.8;
33.9, 29.8, 29.4, 29.3, 28.3, 23.8, 23.4, 11.3; 7.5, 3.3.
Example 16
NMR peaks at: 184.7,181.5,153.0,134.8, 132.9, 132.8,129.5,126.8,126.0,124.9;
34.0,29.9,29.5, 29.3, 28.3,23.9,23.4, 12.6; 18.7,17.5,15.6.
Example 17
NMR peaks at: 184.7, 181.5, 153.1, 134.8, 133.0, 132.8, 129.5, 126.8, 126.0, 124.9;
33.7, 29.9, 29.4, 29.3, 28.3, 23.9, 23.4, 18.0; 18.4, 17.4, 15.3, -3.3.
Example 18
Preparation of 2-hvdroxy-3-(8-ri-methvl-rtetramethylenesilyl^octylV1.4-naphthoquinone
Formula I : m=l. n=0; R1 & R2 together and R7 & R8 together both represent a group =O;
R3 = -OH; R4=R5=H and R6= -(CH2)7SiCH3(CH2)4.
-17-
A solution of dibromobutane (20.0g, 92.6 mmol) in dry THF (100ml) was slowly added to
magnesium turnings (4.5g, 185 mmol). After addition was complete the mixture was
refluxed for Ih and cooled to room temperature. A solution of trimethylsilylchloride
(13.8g, 92.6 mmol) in THF (10ml) was added dropwise and refluxing was continued for
30 minutes. The cooled solution was added dropwise to a preformed solution of octyl
dimagnesium dibromide, as described in Example 14. The mixture was refluxed for Ih
before cooling to room temperature and gaseous carbon dioxide was bubbled through the
solution for 30 minutes. The residue was acidified with dilute hydrochloric acid and
extracted with ether (4x 50ml). The combined ether layers were washed with water
(2x50ml), saturated sodium chloride solution (50ml) and dried (MgSO4). Filtration and
evaporation of the solvent under reduced pressure gave an off-white waxy solid, that was
extracted with hexane (3x50ml). The combined hexane extracts were evaporated under
reduced pressure to yield a pale yellow oil. This liquid was reacted with 2-benzoyloxy-l,4-
naphthoquinone, by the method described in Example 1 followed by the method described
in Example 2 to give 2-hydroxy-3(8-(l-methyl-(tetramethylenesilyl))octyl)-l,4-
naphthoquinone(161mg),m.pt 42-44°C.NMR peaks at: 184.7,181.5,153.0,134.8,132.9,
132.8,129.4,126.8,126.1,124.8; 33.5,29.8,29.4,29.3,28.3,24.3, 23.4; 27.4, 15.1, 11.8,
-3.2.
Example 19
Preparation of 2-hydroxy-3-r8-(l-methyl-(pentamethylenesilvDN)octylV1.4-naphthoquinone
Formula I :m=l. n=0; R1 & R2 together and R7 & R8 together both represent a group =O;
R3 = -OH; R4=R5=H and R6= -(CH2)7SiCH3(CH2)5.
By a process identical to that described in Example 17, but replacing dibromobutane with
dibromopentane, gave 2-hydroxy-3-(8-( 1 -methyl-(pentamethylenesilyl))octyl)-1,4-
naphthoquinone(10mg),m.pt.38-40°C.NMR peaks at: 184.7,181.5, 153.0, 134.8, 133.0,
132.9,129.5, 126.8, 126.1,124.9; 33.6,29.8,29.4,29.3,28.3, 23.7, 23.4, 14.1; 30.2, 24.5,
12.9, -4.8.
Example 20
Preparation of 2-hydroxy-3-ri-propenyl-3-trimethylsilyl)-l .4-naphthoquinone
-18-
Formula I : m=0, n=0; R1 & R2 together and R7 & R8 together both represent a group =O;
R3 = -OH; R4=R5=H and R6= -CH=CH-CH2Si(CH3)3.
To a stirred solution of 3-trimethylsilylpropanol (5.00g, 37.8 mmol) in dichloromethane
(120ml) at room temperature was added pyridinium chlorochromate (16.3g, 75.6 mmol).
The mixture was stirred for 2h and then filtered through silica gel, eluting with ether. The
filtrate was evaporated under reduced pressure to give a colourless liquid (3.96g).
To a stirred solution of the previously prepared liquid (l.OOg) in dichloromethane (30ml)
at room temperature, was added 2-hydroxy-l,4-naphthoquinone (1.1 Ig, 6.40 mmol), and
pyrrolidine (569mg, 8.00 mmol). The reaction was stirred for 15h before p-toluenesulphonic
acid (3.04g, 16.0 mmol) was added, and stirring at room temperature was
continued for a further 24h and refluxing for 3h. The mixture was cooled and the solvent
evaporated under reduced pressure. The residue was dissolved in ether (50 ml) and washed
with water (2x25ml), dilute hydrochloric acid (25ml), water (25ml), saturated sodium
chloride solution (25ml), and dried (MgSO4). Filtration and evaporation of the solvent
under reduced pressure and chromatography eluting with hexane/ether gave 2-hydroxy-3-
(l-propenyl-3-trimethylsilyl)-l,4-naphthoquinone (123 mg) m. pt 72-74°C. NMR peaks
at: 184.6, ca 182, 150.5, 134.7, 133.0, 132.8, ca 129,126.9, 125.8, ca 120; 142.5, 117.0,
27.4;-1.8.
Example 21
Preparation of 2-emanoyloxy-3-r9-trimethylsilylnonyl)-1.4-naphthoquinone
(Formula I : m=l; n=0; R* and R^ together and R' and R° together
both represent =0: R3 = -O-CO-CH3: R4 = R5 = H: R6 = - By a process identical to that described in Example 4 on 2-hydroxy-3-(9-
trimethylsilylnonyl)-!,4-naphthoquinone, Example 12, gave 2-ethanoyloxy-3-(9-
trimethylsilylnonyl)-1,4-naphthoquinone, m. pt.45-47°C. NMR peaks at: 184.5, 178.1,
151.1,139.9, 134.0, 133.8,132.1, 130.9,126.7,126.6; 33.6, 29.7, 29.4, 29.4, 29.3, 28.5,
24.3, 24.0, 16.7; -1.6; 168.0, 20.4 (COCH3).
Example 22
Preparation of 2-propanoyloxy-3-(9-trimethylsilylnonvl)-l .4-naphthoquinone
-19-
(Formula I : m=l; n=0; R1 and R2 together and R7 and R8 together
both represent =0; R3 = -O-CQCH2CH2CH3^R4 = R5 = H: R6 =-fCH2USi£CH3}3
To a stirred solution of 2-hydroxy-3-(9-trimethylsilylnonyl)-l,4-naphthoquinone, Example
12, (lOOmg, 0.27 mmol) in dry dichloromethane (10ml) at room temperature was added
pyridine (0.5ml) and, after 3 minutes, propanoyl chloride (62mg, 0.67 mmol). The reaction
was stirred for 2h before diluting with dichloromethane (50ml), washing with water
(2x30ml), dilute hydrocholic acid (30ml), saturated sodium chloride solution (30ml) and
dried (MgSO4). Filtration and evaporation of the solvent under reduced pressure and
chromatography, eluent hexane/ether, gave 2-propanoyloxy-3-(9-trimethylsilylnonyl)-l,4-
naphthoquinone (112mg). m. pt. 41-43°C. NMR peaks at :184.6, 178.2, 151.2, 139.8,
134.0,133.7,132.1,130.9,126.7,126.5,33.6,29.7,29.4,29.4,29.3,29.3,28.5,24.3,23.9,
16.7, -1.6; 171.6, 27.3, 9.1 (COCH2CH3)
Example 23
Preparation of 2-vinylcarbonato-3-(9-trimethylsilylnonyl)-1.4-naphthoquinone
(Formula I : m=l; n=0; R1 and R2 together and R7 and R8 together
both represent =Q: R3 = -Q-CO-O-CH=CH2: R4 = R5 = H: R6 = -rCH2lgSirCH3l3
To a stirred solution of 2-hydroxy-3-(9-trimethylsilylnonyl)-l,4-naphthoquinone,
Example 12, (lOOmg, 0.27 mmol) in dry dichloromethane (10ml) at room temperature was
added pyridine (0.5ml) and, after 3 minutes, vinyl chloroformate (43mg, 0.40 mmol). The
reaction was stirred for 2h before diluting with dichloromethane (50ml), washing with
water (2x30ml), dilute hydrocholic acid (30ml), saturated sodium chloride solution (30ml)
and dried (MgSO4). Filtration and evaporation of the solvent under reduced pressure and
chromatography, eluent hexane/ether, gave 2-vinylcarbonato-3-(9-trimethylsilylnonyl)-l,4-
naphthoquinone (79mg), nD1.5123 NMR peaks at: 184.6, 178.0, 149.9, 139.9, 134.6,
134.3,132.3,130.9, 127.1, 126.8, 33.9, 30.6, 30.0,29.7, 29.6, 29.6, 29.5, 28.8, 24.5, 24.2,
16.9, -1.3; 149.8,142.8, 99.8 (-O-CO-O-CH=CH2).
Example 24
Preparation of 2-ethoxymethoxy-3 -(9-trimethylsilylnonyl)-1.4-naphthoquinone
(Formula I : m=l: n=0: R! and R2- together and R7- and R8- together
-20-
both represent =0: R3 = -Q-CH2OCH2CH3: R4 = R5 = H: R6 = -(CH2)sSi(CH3^
To a stirred solution of 2-hydroxy-3-(9-trimethylsilylnonyl)-l,4-naphthoquinone, Example
12, (SOOmg, 2.06 mmol) in dry dichloromethane (20ml) at room temperature was added
diisopropylethylamine (1.33g,10.3 mmol) and, after 3 minutes, ethoxymethyl chloride
(831mg, 10.3 mmol) in dichloromethane (5ml). The reaction was stirred for Ih before
diluting with dichloromethane (30ml), washing with water (2x20ml), dilute hydrochloric
acid (20ml), saturated sodium chloride solution (20ml) and drying (MgSO4). Filtration and
evaporation of the solvent under reduced pressure and chromatography, eluent
hexane/ether, gave 2-ethoxymethoxy-3-(9-trimethylsilylnonyl)-l ,4-naphthoquinone
(567mg), nD 1.5182. NMR peaks at : 185.3, 181.6, 155.5, 137.1, 133.8, 133.2, 132.0,
131.4, 126.3, 126.2, 33.6, 30.1, 29.5, 29.4, 29.3, 28.9, 24.1, 23.9, 16.7, -1.6; 96.9, 65.8,
15.0(0-CH2-0-CH2CH3).
Example 25
Preparation of 2-hydroxy-3-(2-(4'.4'-dimethyl-4'-silacyclohexylVpropylV1.4-
naphthoquinone.
CFormula I as Example 24 with R6 =-(CH2)3 -(C5H9SiXCH3^2..
To a stirred solution of 4,4-dimethyl-4-silacyclohexanone (prepared as described in
Sonderquist andNegron; J. Org. Chem.)(900mg, 6.32mmol), ethylcyanoacetate (716 mg,
6.32mmol) and piperidine (215 mg) in benzene (30ml) at room temperature was added
acetic acid (760mg) and the mixture was refluxed under azeotropic conditions for 21/2 hours.
The reaction mixture was cooled to room temperature, diluted with ether (30ml) and
washed with water (2 x 25ml), saturated sodium chloride solution (25ml) and dried
(MgSO4). Filtration and evaporation of solvents under reduced pressure and
chromatography using hexane/ether eluent gave a colourless liquid (0.52g).
This liquid was dissolved in ether (5ml) and added dropwise to a solution of methyl
magnesium bromide (30mg, 1.8mmol) in ether (20ml) stirring at 0°C, under nitrogen. The
mixture was stirred for a further 2 hours before diluting with ether (25ml), water (10ml),
and acidifying with dilute hydrochloric acid. The aqueous layer was separated and extracted
further with ether (2 x 25ml) and the combined ether extracts were washed with water (2
x 20ml), saturated with sodium chloride solution (20ml) and dried (MgSO4). filtration and
-21-
evaporation of solvents under reduced pressure gave a colourless oil which was treated with
potassium hydroxide (550mg) in ethylene glycol and refluxed for 16 hours. The reaction
mixture was cooled to room temperature, diluted with water (40ml) and washed with ether
(2 x 25ml). The aqueous layer was acidified with dilute hydrochloric acid and extracted
with ethyl acetate (4 x 25ml). The combined extracts were washed with water (2 x 20ml),
saturated sodium chloride solution (20ml) and dried (MgSO4). Filtration and evaporation
of solvents under reduced pressure gave a near colourless liquid (300mg).
This liquid was subjected to a process similar to that described in Examples 1 and
2 above to give 2-hydroxy-3-(2-(4',4'-dimethyl-4-silacyclohexyl)propyl)-l,4-
naphthoquinone.
Example 26
Pesticidal Activity
Pesticidal activity was assessed against houseflies, mustard beetles, mites and
whitefly using the following methods.
Houseflies (MD) (Musca domestica)
Female flies were treated on the thorax with a one microlitre drop of test compound
dissolved in acetone. Two replicates of 15 flies were used at each dose rate and 6 dose
rates were used per compound under test. After treatment, the flies were maintained at a
temperature of 20° ± 1 °C and kill was assessed 24 and 48 hours after treatment. LD5Q
values were calculated in micrograms of test compound per fly (see Sawicki et al,
Bulletin of the World Health Organisation, 35, 893 (1966) and Sawicki et al,
Entomologia and Exp. Appli 10, 253, (1967).
Mustard beetles (PC) (Phaedon cochleariae Fab)
A one microlitre drop of an acetone solution of the test compound was applied
ventrally to adult mustard beetles using a micro drop applicator. The treated insects were
maintained for 48 hours after which time kill was assessed. Two replicates each of 20
to 25 mustard beetles were used at each dose level and 5 dose levels were treated
comparably. LD5Q values were calculated as for houseflies.
Mites (TU) (Tetranychus urticae)
25 adult female mites were immersed in 35 ul of a solution of the test compound
-22-
in a 1:4 acetone-water mixture for 30 seconds. The treated insects were maintained
at 21 ° ± 2°C and kill was assessed 72 hours after treatment. Mites exhibiting repetitive
(non-reflex) movement of more than one locomotory appendage after this period were
recorded as alive. Three replicates of 25 mites each were used at each dose rate and 5
or 6 dose rates were used per compound under test. LC5Q values were calculated in ppm
of the solution of the test compound per insect. The test was carried out using a susceptible
strain of mites (GSS) supplied by Schering, AG, Berlin.
Whiteflv (ED rBemisia tabaci)
Acetone solutions (0.100 ml) of the test compounds were placed in 10 ml glass vials
and evaporated with rotation to deposit a film of the compound. Thirty adult whiteflies
were placed inside the vial, then after 60 minutes, the treated insects were transferred onto
untreated cotton leaf discs which were kept moist on a bed of agar gel. The temperature
was maintained at 25 °C and mortality assessed after 48 hours. Three replicates were used
at each of 5 to 7 dose levels per compound. LC5Q values were calculated by using a
computer software package ("Polo-PC available from LeOra Software, Berkeley,
California). (See M.R. Cahill and B. Hackett in Proceedings Brighton Crop Protection
Conference, 1992). The test was carried out using a susceptible strain of whitefly (SUD-S)
which was collected in Sudan in 1978 from cotton.
The results of these tests are set out in Table 3 below. The values given are
LD50 (fig/insect) or LC50 (ppm solution of test compound) unless otherwise specified.
-23-
TABLE 3
Compound
Example No
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
MD
(LD50)
>20
0.69
1.3
c.20
>20
-
4.4
1.8
1.8
1.7
2.3
2.8
9.9
-
_
.
-
.
.
-
c2
-
-
-
PC
(LD50)
>20
0.45
c.1.0
c.2.0
c.20
c.20
c.8
C.I
C.I
c.0.2
C.I
0.13
c.0.6
c2
c2
>20
C.I
c.2
c.2
>20
c2
c2
c2
c20
TU (GSS)
(LC50)
110
38
2.8
45
41
-
6.4
9.2
4.5
0.31
0.51
0.9
2.2
c2
5.2
-
8.4
3.6
-
21
2.0
c20
c50
-
BT (SUD-S)
(LC50)
2.6
6.8
2.9
.
1.7
c.9
clO
100%
8.2
14.6
8.6
-
15
22
79%*
13
.
13%*
30
clOO
32%*
19%*
-24-
* = kill at 100 ppm. - = not done.
Example 27
Aphicidal activity
Activity against resistant (R) and susceptible (S) strains of aphid fMyzus Persicae) and
Aphis Gossypiae was assessed using the following two methods.
Topical application:
Batches of 10-15 apterous adults were removed from stock cultures and placed on leaf discs
(35mm in diameter) cut from Chinese cabbage and held on an agar bed (25mm deep) in
disposable plastic containers (30mm high). Using a Burkhard micro-applicator aphids were
dosed individually with a 0.25 ^m droplet of chemical diluted to the required concentration
in acetone, control insects were dosed with acetone only. Mortality and other effects were
scored at 24 hour intervals up to and including 72 hour post-treatment, the end-point to
which the results relate.
Aphid-dip:
Entrapment rings of fluon were painted halfway up the inside of 4 cm lengths of glass
tubing (1.5 cm diameter), and squares of insect-proof gauze were attached to one end of
each tube by elastic bands. Fifteen apterous adults were then gently transferred into the
tubes using a sable-hair brush, and the tube sealed with a second gauze square.
Tubes containing aphids were dipped into insecticide solutions for 10 seconds, dried
on blotting paper, and then inverted and tapped to cause treated aphids to fall to the
unimmersed end of each tube. Handling mortality (usually zero or very slight) was scored
after 1 hour, when aphids were transferred onto Chinese cabbage leaf-discs (35 mm
diameter) on an agar bed (25 mm in depth) in disposible plastic containers (30 mm high)
and confined by applying a ring of fluon to the exposed lip of the container. Containers
were stored upright, without lids, in a constant environment facility maintained at 25°C
under continuous room lighting. Mortality was assessed at 24, 48 and 72 hours. Two
replicates of 15 aphids each were used at each dose rate and 5 or 6 dose rates were used per
compound under test.
-25-
The test was carried out using a susceptible strain of aphids (US1L) collected in the
field in East Anglia, UK and an extremely resistant strain of aphids (794 Jz) (R3 esterase,
sensitive AChE) collected from glasshouses in the UK.
The results of this test are set out in Table 5 below. The values given are %
mortality corrected for control data. The control comprised the test solution without active
ingredient.
TABLE 4:TOPICAL APHID RESULTS
All results quoted as % kill at 100 ppm unless otherwise indicated.
EXAMPLE
NO.
2
3
7
8
9
10
11
12
13
14
15
16
17
18
21
22
23
24
M.P.
USIL 794JZ
45
100
45
90
100
100
100
89
90
74
58
24
88
59
66^)
37
63
16
100 0)
95
89
1000 ppm 125 ppm
-26-
TABLE 5
APHID-DIP RESULT
All quoted as % kill at 100 ppm
EXAMPLE
NO.
2
3
4
7
8
9
10
11
12
13
21
M.P.
USIL 794JZ
77
100
19
90
90
100
100
100
100
90
66
54
19
100
61
A.G.
81-171B
63
100
57
71
100
100
93
83
MP - Myzus AP = Aphis
Example 28
Fungicidal Activity
Fungitoxicity of coded compounds to isolates of Aspergillus niger.
Pyricularia oryzae (=Magnaporthe grisea) and Rhizoctonia solani was tested in vitro.
Each compound was incorporated into potato dextrose agar in solvent
(50/50 ethanol/acetone) at 0.5 ml solvent per 250 ml agar while the autoclaved agar was
still molten and cooled to 50°C. Each compound was tested at a single concentration
(100 mgr1).
Each test, usually of two compounds, included three control treatments: a standard
fungicide (carbendazim at 1 or 5 mg 1"^ or prochloraz at 1 mg 1"1); ethanol/acetone only;
no additions. The fungicides used as standards may be considered as representative of
active, commercially available compounds.
-27-
Each fungus was tested on agar in four Petri dishes per treatment, with three
replicate fungal colonies per plate (one colony for R. solani). A. niger and R. solani were
incubated for 4 days at 20-25°C, and P. oryzae for 7 days. Increase in colony diameter was
then measured and used to determine activity.
The results of these tests are set out in Table 6 below. The values given are %
inhibition of growth in colony diameter in agar plates.
-28-
TABLE 6
Compound of Example
No.
2
2
2
Prochloraz
Carbendazim
Carbendazim
Fungus
A. niger
P. oryzae
R. solani
A. niger
P. oryzae
R. solani
Activity at lOOmgl"1
18
67
35
Activity at
5 mg I'1
99.8
82.4
Activity at
Imgl'1
97.8
14.7
3.3
-29-
In addition, tests have shown that the compounds of formula I exhibit good fungicidal
activity against a broad spectrum of fungi which cause diseases in both cereal and broad
leaved crops. Particularly, good activity has been observed against fungi of the genera
Erysiphe. especially Erysiphe graminis. and Botrytis. especially Botrytis fabae and
Botrytis cinerea. as well as the genera Rhizoctonia. Pyricularia and Aspergillus as
illustrated above.
Table 7 below shows the pesticidal activity of comparative naphthoquinone compounds of
the prior art in order to better illustrate the relative efficacy of the compounds of the
invention. The activities listed were obtained using the methods outlined in Examples 27
and 28 above.
Regarding the prior art naphthoquinone of DE 3801743; EP 0300218 Al lists its activity
against Tetranychus as less than the corresponding tertiary butyl compound (see Tabelle
A of EP 0300218 Al). That t-butyl compoud has been tested by the present inventors and
found to have LC50 values of 44ppm/insect against Tetranycus and 18ppm against Bemisia
;LD50 values of 16 ug/insect against Musca and 0.53 ug/insect against Phaedon and give
19% kill against Myzus in the tests set out above.
-30-
TABLE 7 Comparative Examples R^R2 and R7R8 = =0; R3 = OH
Naphthalene
3 position
-H
5 -CH3
-CH2CH3
-(CH2)2CH3
-(CH2)3CH3
-(CH2)4CH3
10-(CH2)5CH3
-(CH2)7CH3
-(CH2)9CH3
-(CH2)1OCH3
-(CH2)11CH3
[5-(CH9)i3CH^
PC
LD50 ((ig/insect)
NA
NA
NA
clO
c5
c7
c7
0.78
1.9
cO.4
NA
NA
MD
LD50
(|ag/insect)
NA
NA
NA
NA
clO
NA
c20
1.9
NA
NA
NA
NA
MP
%kill lOOppm
-
-
-
-
-
-
0
-
-
-
0
-
TU
LC50
(ppm/insect)
NA
NA
NA
clOOO
65
16
170
clOOO
5.5
1.4
1.3
BT
LC50
(ppm/insect)
NA
NA
NA
80
13
17
9.4
19
>100
>100
>100
NA
-31-
In order to exemplify the preparation of naphthoquinone rings bearing substituents at the
5, 6, 7 and/or 8 positions the following Examples 29 to 31 are provided.
Example 29
Preparation of 2-(t-butyl)-3-hydroxy-6-methyl-naphthalene-1.4-dione and 2-(t-butyl)-3-
hydroxy-7-methyl-naphthalene-1.4-dione.
(a) Preparation of 6-methyl-naphthalene-1.4-dione.
A solution of 1,4-benzoquinone (13.9 g, 128 mmol) and isoprene (13.1 ml,
131 mmol) was stirred in glacial acetic acid (44 ml) for 68 hours at room temperature. The
mixture was diluted with water (44 ml) and refluxed for 1 Vz hours. The mixture was cooled
to room temperature and acetic acid (84 ml) and chromic acid [chromium trioxide (29.4 g)
in water (30 ml)] was added sequentially, before refluxing for a further 1 Vi hours. After
cooling, the mixture was diluted with water (200 ml) and extracted with ether (3 x 50 ml).
The combined ether fractions were washed with dilute sodium hydroxide solution (2M; 2
x 50 ml), water (2 x 50 ml), saturated sodium chloride solution (50 ml) and dried over
magnesium sulphate. Filtration and evaporation of solvent under reduced pressure, and
repeated recrystallisation from petroleum ether yielded the title compound (7 g).
(b) 2-Amino-6 and 7-methyl-1.4-naphthalene-1.4-diones.
To a stirred solution of 6-methyl naphthalene-1,4-dione (2.1 g, 12 mmol) in glacial
acetic acid (60 ml) at room temperature was added a solution of sodium azide (1.58 g) in
water (5 ml). The mixture was stirred for 2 days before diluting with water (200 ml) and,
after stirring for a further 15 minutes, was filtered. The filtrate was neutralised with sodium
bicarbonate and extracted with chloroform (3 x 25 ml). The combined chloroform extracts
were washed with saturated sodium bicarbonate solution, brine and dried (CaSC^).
Filtration and evaporation of solvent under reduced pressure and silica gel chromatography
yielded the title compound (100 mg) as a 3:2 mixture of isomers.
(c) 2-Hydroxy-6- and -7-methyl-naphthalene-1.4-diones.
The aminomethyl naphthalene-1,4-dione mixture from (b)(200 mg) was refluxed
in water (20 ml) and concentrated sulphuric acid (10 ml) for 20 minutes. The cooled
mixture was poured into ice/water (50 g) and extracted with ether (3 x 25 ml). The
combined ether extracts were washed with water, saturated NaHCC^, water, saturated NaCl
-32-
solution and dried (MgSo4). Filtration and evaporation of solvent and purification by
silica gel column chromatography yielded the title compound (68 mg).
(d) Preparation of 2-rt-butvn-3-hvdroxv-6 and 7-methvl-3-hvdroxv-naphthalene-1.4-
diones.
Standard peroxysulphate/silver nitrate radical addition on the aminomethyl
compound (64 mg, 0.34 mmol), trimethylacetic acid (52 mg, 0.51 mmol), yielded the title
compound as a 3:2 mixture of isomers (12 mg).
Example 30
Preparation of 2-(t-butyl)-6 and 7-dimethyl-3-hydroxy-naphthalene-1.4-diones
Steps (a) to (d) above were repeated, replacing isoprene with
2,3-dimethyl-l,3-butadiene.
Example 31
Preparation of 2-(t-butylV3-hydroxy-5 and 8-methyl-1.4-naphthalene-1.4-diones
Steps (a) to (d) above were repeated, replacing isoprene with piperylene.
(a) Preparation of 6-methyl-1.4-naphthalene-1.4-dione.
A solution of 1,4-benzoquinone (13.9 g, 128 mmol) and isoprene
(13.1 ml, 131 mmol) was stirred in glacial acetic acid (44 ml) for 68 hours at room
temperature. The mixture was diluted with water (44 ml) and refluxed for 11A hours. The
mixture was cooled to room temperature and acetic acid (84 ml) and chromic acid
[chromium trioxide (29.4 g) in water (30 ml)] was added sequentially, before refluxing for
a further 1 1A hours. After cooling, the mixture was diluted with water (200 ml) and
extracted with ether (3 x 50 ml). The combined ether fractions were washed with dilute
sodium hydroxide solution (2M; 2 x 50 ml), water (2 x 50 ml), saturated sodium chloride
solution (50 ml) and dried over magnesium sulphate. Filtration and evaporation of solvent
under reduced pressure, and repeated recrystallisation from petroleum ether yielded the title
compound (7 g).


We claim:
[ A compound comprising a naphthoquinone derivative of the general formula

(Formula Removed)
or a salt thereof, in which m is 0 or 1 and n represents an integer from 0 to 4, wherein,
each R independently represents a halogen atom or a nitro, cyano, hydroxyl, alkyl, haloalkyl, alkoxy, haloalkoxy, amino, alkylamino, dialkylamino, alkoxycarbonyl, carboxyl, alkanoyl, alkyithio, alkylsulphinyi, alkylsulphonyl, carbamoyl, alkylamido, cycloalkyl, aryl or aralkyl group;
R1 and R2 each independently represent an optionally substituted alkoxy group or together
represent a group =0, =S or =N-OR9, where R9 represents a hydrogen atom or an
optionally substituted alkyl group;
R3 represents a hydroxy! group, or a group -OL where L is a leaving group or a group
which in vivo is transformed into a group -L1 where L1 is a leaving group;
R4 and R5, if present, each independently represent a hydrogen or halogen atom or an
optionally substituted alkyl group or together with the interjacent carbon atom represent an
optionally substituted cycloalkyl or cycloalkenyl group optionally containing at least one
ring-silicon atom;
R6 represents an optionally substituted group containing at least one silicon atom or, in the
case where m is 1 and the -CR4R5-moiety contains at (east one silicon atom, R6 may
additionally represent a hydrogen atom or an optionally substituted alkyl, alkenyl, alkynyl,
cycloalkyl, cycloalkenyl, aryl, alkoxy, alkenyloxy, alkynyloxy, cycloalkoxy,
cycloalkenyloxy or aryloxy group; and
R7 and R8 independently represent an optionally substituted aikoxy group or together
represent a group =0, =S or -N-OR9, where R9 is as previously defined;
wherein, when R6 represents an optionally substituted group containing at least one silicon

atom, at least one of the silicon atoms of R6 is not directly attached to a carbocylic ring.
2. A compound as claimed in claim 1 in which R, if present, represents a halogen atom or a nitro, cyano, hydroxyl, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, C1-4 alkylamino, di-C1-4 alkylamino, C1-4 alkoxycarbonyl, C1-4 alkylthio, C1-4 alkylsulphinyl or C1-4 alkylsulphonyl group.
3. A compound as claimed in claim 1 in which n is 0.
4. A compound as claimed in any one of the preceding claims in which R1 and R2 each independently represent a C1-4 alkoxy group or together represent a group =0 or =N-OR9, where R9 represents a hydrogen atom or a, C1-4 alkyl group.

5. A compound as claimed in any one of the preceding claims in which R3 represents a group -OR10 where R10 represents a hydrogen atom, an optionally substituted alkyl, aryl or aralkyl group or a group -CO-R11, -SO-R11, -SO2-R11 -P(X)(OR12)(OR13), -P(X)(R12)(OR13), -P(OR12)(OR13) or -P(R12)(OR13) where R11 represents a hydrogen atom, an optionally substituted alkyl, aryl or aralkyl group or a group - NR12R13, R12 and R13 independently represent a hydrogen atom or an optionally substituted alkyl group and X represents an oxygen or sulphur atom.
6. A compound as claimed in any one of the preceding claims in which R3 represents a hydroxyl group or a group -O-CO-R11 where R11 represents a hydrogen atom or a C1-12 alkyl, C1-12 haloalkyl, C1-12 hydroxyalkyl, C1-12 carboxylalkyl, phenyl or benzyl group.
7. A compound as claimed in any one of the preceding claims in which R4 and R5 each independently represent a hydrogen atom or a C1-4 alkyl group.

8. A compound as claimed in any one of claims 1 to 6 in which R4 and R5 together
with the interjacent atom represent a C3-8 cycloalkyl group optionally substituted
by one or more substituents selected from halogen atoms, C1-4 alkyl and C1-4
haloalkyl groups.
9. A compound as claimed in any one of the preceding claims in which R6
represents an alkyl, haloalkyl, alkoxyalkyl, alkoxy, haloalkoxy, alkoxyalkoxy,
alkenyl, haloalkenyl or alkoxyalkenyl group, each group containing one or two
silicon atoms and up to 20 carbon atoms.
10. A compound as claimed in any one of claims 1 to 6 in which R4 and R5 together with the interjacent carbon atom represent a silacycloalkyl group containing from 3 to 8 ring atoms optionally substituted by one or more substituents selected from halogen atoms, C1-4 alkyl or C1-4 haloalkyl groups.
11. A compound as claimed in claim 10 in which R6 represents a hydrogen atom or an alkyl, haloalkyl, alkoxyalkyl, alkoxy, haloalkoxy, alkoxyalkoxy, alkenyl, haloalkenyl or alkoxyalkenyl group, each group optionally containing one or two silicon atoms and up to 12 carbon atoms.
12. A compound as claimed in any one of the preceding claims in which R7 and R8 independently represent a C1-4 alkoxy group or together represent a group =0 or =N-OR9, where R9 represents a hydrogen atom or a C1-4 alkyl group.
13. A compound as claimed in any one of claims 1 to 12 wherein R6 is of the
formula -(A)m-Si(R14)3 where m is as defined for formula (I), each R14 is
independently C1-4 alkyl or two of these groups together with the interjacent silicon
atom form a C3-8 silacarbocyclic ring, and A is a C1-20 alkyl or alkenyl group, which
may be substituted with halogen, and which may be straight, branched or be or
include a carbocyclic ring.

14. A compound as claimed in any one of claims 1 to 12 wherein R6 includes silicon as a ring atom in an otherwise carbocyclic ring.
15. A compound as claimed in any one of claims 1 to 12 wherein R6 represents a group -(CH2)P,-Si(R14)3 where p represents an integer from 1 to 15, preferably 1 to 10 and especially 1 to 6, and each R14 independently represents a C1-4 alkyl group or two groups R14 form a 3-8 membered silacarbocyclic ring together with the interjacent silicon atom shown.
16. A compound of formula (I) or a salt thereof as claimed in any one of the claims 1 to 15 when used in a pesticidal composition along with a carrier.
17. A compound of formula I as claimed in claim 1 substantially as hereinbefore described and with reference to any one of Examples 1 to 26.

Documents:

0763-del-1999-abstract.pdf

0763-del-1999-claims.pdf

0763-del-1999-correspondence-others.pdf

0763-del-1999-description (complete)-14-07-2008.pdf

0763-del-1999-description (complete).pdf

0763-del-1999-form-1.pdf

0763-del-1999-form-18.pdf

0763-del-1999-form-2.pdf

0763-del-1999-form-4.pdf

0763-del-1999-form-6.pdf

763-del-1999-correspondence-others- (14-07-2008).pdf

763-del-1999-petition-137-(14-07-2008).pdf

763-del-1999-petition-138-(14-07-2008).pdf

abstract.jpg


Patent Number 222258
Indian Patent Application Number 0763/DEL/1999
PG Journal Number 34/2008
Publication Date 22-Aug-2008
Grant Date 04-Aug-2008
Date of Filing 20-May-1999
Name of Patentee BRITISH TECHNOLOGY GROUP LIMITED
Applicant Address 101 NEWINGTON CAUSEWAY, LONDON SE1 6BU, ENGLAND.
Inventors:
# Inventor's Name Inventor's Address
1 STUART CAMERON 35 FELBRIGG CLOSE, LUTON, BEDFORDSHIRE, LU2 8UL, ENGLAND
2 BHUPINDER PALL SINGH KHAMBAY 123 TENTELOW LANE, NORWOOD GREEN, SOUTH, MIDDLESEX, UB2 4LW, ENGLAND
3 DUNCAN BATTY 14 BALLIOL ROAD, KEMPSTON, BEDFORDSHIRE MK42 7ER, ENGLAND
PCT International Classification Number A01N 43/00
PCT International Application Number N/A
PCT International Filing date
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 9513550.5 1995-07-04 U.K.